C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/00 (2006.01) A61K 45/00 (2006.01) A61K 47/00 (2006.01)
Patent
CA 2624601
The invention involves, inter alia, the use of markers of systemic inflammation to determine whether or not an individual undergoing treatment with a cardiovascular agent to reduce the risk of a future cardiovascular event will benefit from continued treatment with the cardiovascular agent. Further, this invention describes the use of markers of systemic inflammation to evaluate the efficacy of treatment and to assist physicians in deciding on the course of a treatment in an individual at risk of future cardiovascular events.
L'invention a trait notamment à l'utilisation de marqueurs d'inflammation généralisée pour déterminer si un sujet traité avec un agent cardiovasculaire de façon à réduire son risque d'accident cardiovasculaire futur tirera profit ou non d'un traitement continu avec ledit agent cardiovasculaire. L'invention concerne en outre l'utilisation de marqueurs d'inflammation généralisée pour évaluer l'efficacité du traitement et aider les médecins à décider du déroulement d'un traitement chez un sujet présentant un risque d'accident cardiovasculaire.
Smart & Biggar
The Brigham And Women's Hospital Inc.
LandOfFree
Relevance of achieved levels of markers of systemic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Relevance of achieved levels of markers of systemic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Relevance of achieved levels of markers of systemic... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1855029